Entire-body PET Scans for Multiple Sclerosis
Part of paid clinical trials in Ladera Ranch, California.
- Sponsor
- Brain Health Alliance
- Study ID
- NCT04390009
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- Entire-body PET-CT scans — DIAGNOSTIC_TESTEntire-body PET-CT scans will be performed with state-of-the-art scanners with different manufacturers' models including Siemens Biograph Vision, United Imaging uEXPLORER and possibly other recently FDA-approved PET-CT scanners.
- Amyvid radiopharmaceutical — DRUGAmyvid (F18-florbetapir) will be evaluated for binding to white matter of the peripheral and central nervous system of participants
Study Details
To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.
Key Dates
- Start date
- Sep 30, 2024
- Status verified
- Jan 2025
- Primary completion
- Sep 30, 2025
- Completion
- Dec 30, 2025
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Siemens Biograph Vision PET-CT scansParallel study arms defined by PET-CT scanners by different manufacturer and model
- Other: United Imaging uEXPLORER PET-CT scansParallel study arms defined by PET-CT scanners by different manufacturer and model
Primary Outcome Measure
Entire-body PET imaging of demyelination of peripheral and central nervous system [ Time Frame: During 1 day single PET-CT scan ]
Central Contacts
- Carl Taswell, MD, PhD949-481-3121
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brain Health Alliance | Ladera Ranch | California | 92694 |
Find similar trials in Ladera Ranch, CA
By condition
By specialty
By research site
Related Studies
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- ECoG BMI for Motor and Speech ControlRecruiting · Karunesh Ganguly · San Francisco, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With MayzentRecruiting · Novartis Pharmaceuticals · La Jolla, California